What’s next in prostate cancer detection technologies?
The PSA test has been the gold-standard treatment for detecting prostate cancer, but key shortcomings have prevented national screening programmes.
29 November 2024
29 November 2024
The PSA test has been the gold-standard treatment for detecting prostate cancer, but key shortcomings have prevented national screening programmes.
These tools are compatible with QIAcuity digital PCR systems and third-party next-generation sequencing (NGS) platforms.
The new 8,000m² site will have offices, manufacturing lines, clean rooms, laboratories, and logistics areas.
Verathon says its new laryngoscope demonstrates that excellence in patient care can coexist with care for the environment.
Set to support a previous Phase III trial ahead of authorisation applications, the new Chinese trial is set to examine the systems use on clear cell renal cell carcinomas.
The Swedish company will pay approximately $4.5m cash and promissory convertibles to the Finnish medtech company.
Sequana’s therapy works by removing sodium, with the body then responding with osmotic ultrafiltration and urination.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.